Wayfinding artificial intelligence to detect clinically meaningful spots of retinal diseases: Artificial intelligence to help retina specialists in real world practice.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 14 09 2022
accepted: 20 02 2023
medline: 29 3 2023
entrez: 27 3 2023
pubmed: 28 3 2023
Statut: epublish

Résumé

To aim of this study is to develop an artificial intelligence (AI) that aids in the thought process by providing retinal clinicians with clinically meaningful or abnormal findings rather than just a final diagnosis, i.e., a "wayfinding AI." Spectral domain optical coherence tomography B-scan images were classified into 189 normal and 111 diseased eyes. These were automatically segmented using a deep-learning based boundary-layer detection model. During segmentation, the AI model calculates the probability of the boundary surface of the layer for each A-scan. If this probability distribution is not biased toward a single point, layer detection is defined as ambiguous. This ambiguity was calculated using entropy, and a value referred to as the ambiguity index was calculated for each OCT image. The ability of the ambiguity index to classify normal and diseased images and the presence or absence of abnormalities in each layer of the retina were evaluated based on the area under the curve (AUC). A heatmap, i.e., an ambiguity-map, of each layer, that changes the color according to the ambiguity index value, was also created. The ambiguity index of the overall retina of the normal and disease-affected images (mean ± SD) were 1.76 ± 0.10 and 2.06 ± 0.22, respectively, with a significant difference (p < 0.05). The AUC used to distinguish normal and disease-affected images using the ambiguity index was 0.93, and was 0.588 for the internal limiting membrane boundary, 0.902 for the nerve fiber layer/ganglion cell layer boundary, 0.920 for the inner plexiform layer/inner nuclear layer boundary, 0.882 for the outer plexiform layer/outer nuclear layer boundary, 0.926 for the ellipsoid zone line, and 0.866 for the retinal pigment epithelium/Bruch's membrane boundary. Three representative cases reveal the usefulness of an ambiguity map. The present AI algorithm can pinpoint abnormal retinal lesions in OCT images, and its localization is known at a glance when using an ambiguity map. This will help diagnose the processes of clinicians as a wayfinding tool.

Sections du résumé

AIM/BACKGROUND
To aim of this study is to develop an artificial intelligence (AI) that aids in the thought process by providing retinal clinicians with clinically meaningful or abnormal findings rather than just a final diagnosis, i.e., a "wayfinding AI."
METHODS
Spectral domain optical coherence tomography B-scan images were classified into 189 normal and 111 diseased eyes. These were automatically segmented using a deep-learning based boundary-layer detection model. During segmentation, the AI model calculates the probability of the boundary surface of the layer for each A-scan. If this probability distribution is not biased toward a single point, layer detection is defined as ambiguous. This ambiguity was calculated using entropy, and a value referred to as the ambiguity index was calculated for each OCT image. The ability of the ambiguity index to classify normal and diseased images and the presence or absence of abnormalities in each layer of the retina were evaluated based on the area under the curve (AUC). A heatmap, i.e., an ambiguity-map, of each layer, that changes the color according to the ambiguity index value, was also created.
RESULTS
The ambiguity index of the overall retina of the normal and disease-affected images (mean ± SD) were 1.76 ± 0.10 and 2.06 ± 0.22, respectively, with a significant difference (p < 0.05). The AUC used to distinguish normal and disease-affected images using the ambiguity index was 0.93, and was 0.588 for the internal limiting membrane boundary, 0.902 for the nerve fiber layer/ganglion cell layer boundary, 0.920 for the inner plexiform layer/inner nuclear layer boundary, 0.882 for the outer plexiform layer/outer nuclear layer boundary, 0.926 for the ellipsoid zone line, and 0.866 for the retinal pigment epithelium/Bruch's membrane boundary. Three representative cases reveal the usefulness of an ambiguity map.
CONCLUSIONS
The present AI algorithm can pinpoint abnormal retinal lesions in OCT images, and its localization is known at a glance when using an ambiguity map. This will help diagnose the processes of clinicians as a wayfinding tool.

Identifiants

pubmed: 36972243
doi: 10.1371/journal.pone.0283214
pii: PONE-D-22-25545
pmc: PMC10042340
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0283214

Informations de copyright

Copyright: © 2023 Shiihara et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: the employees of NIDEK CO., LTD. (Shiba, Yoshiki Kumagai, Naoto Honda) This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Med Image Comput Comput Assist Interv. 2019 Oct;11764:120-128
pubmed: 31853524
JAMA Ophthalmol. 2018 Jul 1;136(7):803-810
pubmed: 29801159
JAMA Ophthalmol. 2018 Dec 1;136(12):1359-1366
pubmed: 30242349
Ophthalmology. 2018 Sep;125(9):1410-1420
pubmed: 29653860
Ophthalmology. 2018 Aug;125(8):1199-1206
pubmed: 29506863
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT1-OCT13
pubmed: 27409459
Comput Methods Programs Biomed. 2022 May;218:106732
pubmed: 35279601
Ophthalmol Retina. 2017 Jul-Aug;1(4):322-327
pubmed: 30693348
Br J Ophthalmol. 2022 Sep;106(9):1301-1307
pubmed: 33875452
JAMA. 2021 Dec 28;326(24):2467-2468
pubmed: 34882190
Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5200-5206
pubmed: 27701631
Nat Med. 2020 Jun;26(6):892-899
pubmed: 32424211
Nat Med. 2018 Sep;24(9):1342-1350
pubmed: 30104768
Prog Retin Eye Res. 2018 Nov;67:1-29
pubmed: 30076935
Br J Ophthalmol. 2019 Feb;103(2):167-175
pubmed: 30361278
JAMA. 2017 Dec 12;318(22):2211-2223
pubmed: 29234807
JAMA. 2016 Dec 13;316(22):2402-2410
pubmed: 27898976
IEEE Trans Med Imaging. 2020 Jan;39(1):87-98
pubmed: 31170065
JAMA Ophthalmol. 2019 Mar 1;137(3):288-292
pubmed: 30570648
Nature. 2016 Oct 05;538(7623):20-23
pubmed: 27708329
Nature. 2015 May 28;521(7553):436-44
pubmed: 26017442
JAMA Ophthalmol. 2017 Nov 1;135(11):1170-1176
pubmed: 28973096
Ophthalmology. 2017 Jul;124(7):962-969
pubmed: 28359545
PLoS One. 2021 May 14;16(5):e0251553
pubmed: 33989334

Auteurs

Hideki Shiihara (H)

Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Shozo Sonoda (S)

Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Sonoda Eye Clinic, Kagoshima, Japan.

Hiroto Terasaki (H)

Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Kazuki Fujiwara (K)

Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Ryoh Funatsu (R)

Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Yousuke Shiba (Y)

NIDEK CO., LTD., Gamagori, Japan.

Yoshiki Kumagai (Y)

NIDEK CO., LTD., Gamagori, Japan.

Naoto Honda (N)

NIDEK CO., LTD., Gamagori, Japan.

Taiji Sakamoto (T)

Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH